Follow

Submissions from 2017

Link

Prognostic Significance of Monosomy 7 with and without Complex Karyotypes in Acute Myeloid Leukemia (AML): A Single Institutional Analysis, Daniel E. Ezekwudo, Bolanle Gbadamosi, Leann Blankenship, Susanna Gaikazian, and Dana Zakalik

Link

Breast Implant–Associated Anaplastic Large Cell Lymphoma: A Case Report and Review of the Literature, Daniel E. Ezekwudo, Bolanle Gbadamosi, Michael Stender, and Ishmael Jaiyesimi

Link

Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature., Daniel E Ezekwudo and Ishmael Jaiyesimi

Link

Unusual Presentation of a Small-Cell Variant of Anaplastic Large-Cell Lymphoma Case: When a Septic Picture Is Not Sepsis, Daniel E. Ezekwudo, Foluso Ogunleye, Susanna S. Gaikazian, and Ishmael Jaiyesimi

Link

Primary Extranodal Diffuse Large B-Cell Lymphoma of the Prostate: A Case Report., Daniel E Ezekwudo, Foluso Ogunleye, Bolanle Gbadamosi, LeAnn M Blankenship, and Ishmael Jaiyesimi

Link

The Clinical Characteristics, Genetic Alterations and Prognostic Significance of Acute Myeloid Leukemia (AML) with Trisomy 8, Bolanle Gbadamosi, Daniel E. Ezekwudo, Foluso Ogunleye, Zhou Yu, Michael Stender, Dana Zakalik, Ishmael Jaiyesimi, and Mark Micale

Link

Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients., Ishmael Jaiyesimi

Link

Programmed cell death-1/Programmed cell death ligand-1(PD-1/PD-L1) inhibitors, heralding a new era of immunotherapy in the management of advanced Non-Small Cell Lung Cancer (NSCLC), Ishmael Jaiyesimi

Link

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update., Ishmael Jaiyesimi

Link

Representation of minorities and elderly in cancer clinical trials at a single institution-The William Beaumont Hospital experience, Foluso Ogunleye

Link

Crizanlizumab in Sickle Cell Disease., Zhou Yu, LeAnn Blankenship, and Ishmael Jaiyesimi

Link

Excellent Response with Ado-Trastuzumab Emtansine in a Patient with Relapsed Metastatic Breast Cancer Presenting with Pulmonary Lymphangitic Carcinomatosis., Zhou Yu and Marianne Huben